Stay updated on Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy

Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding three more interventions/treatments and noting that the study now has 56 locations.
    Difference
    0.3%
    Check dated 2024-07-23T15:30:48.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T08:54:45.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the web page content.
    Difference
    0.0%
    Check dated 2024-07-02T15:57:01.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.
    Difference
    0.0%
    Check dated 2024-06-27T11:57:40.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent change in the webpage content.
    Difference
    0.0%
    Check dated 2024-06-26T10:35:31.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less MedlinePlus Genetics related topics: Breast cancer MedlinePlus related topics: Breast Cancer Drug Information available for: Trastuzumab Pertuzumab FDA Drug and Device Resources'. This change represents an update in the information displayed on the webpage related to the study on Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
    Difference
    89%
    Check dated 2024-06-25T09:36:09.000Z thumbnail image

Stay in the know with updates to Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy

Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page.